In accordance with the ACCME Standards for Integrity and Independence, Global Learning Collaborative (GLC) requires that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any ineligible company. GLC mitigates all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all its educational programs.
Faculty:
Richard Channick, MD
Director, Pulmonary Vascular Disease Program
UCLA Medical Center
Los Angeles, CA
Dr. Channick has reported the following relevant financial relationships or relationships with ineligible companies of any amount during the past 24 months:
Research: Aria CV, Janssen
Vallerie McLaughlin, MD
Professor, Internal Medicine
University of Michigan
Ann Arbor, MI
Dr. McLaughlin has reported the following relevant financial relationships or relationships with ineligible companies of any amount during the past 24 months.
Research: Aerovate, Altavant, Gossamer Bio, Janssen, Merck, SoniVie
Consulting fees: Aerami, Aerovate, Altavant, Bayer, Caremark, CorVista, Gossamer Bio, Janssen, Merck, United Therapeutics
Ioana Preston, MD
Associate Professor of Medicine
Tufts University School of Medicine
Boston, MA
Dr. Preston has reported the following relevant financial relationships or relationships with ineligible companies of any amount during the past 24 months:
Research: Acceleron/Merck, Actelion/Janssen, Keros, Liquidia, Respira, United Therapeutics
Consulting fees: Acceleron/Merck, Actelion/Janssen, Aerovate, Gossamer, Keros, Liquidia, Respira, United Therapeutics
Reviewers/Content Planners/Authors:
- Cindy Davidson has nothing to disclose.
- Susan Diaz has nothing to disclose.
- Brian P. McDonough, MD, FAAFP, has nothing to disclose.
- Prerna Poojary has nothing to disclose.
- Leticia Samaras has nothing to disclose.
- Katie Sheridan has nothing to disclose.